The expanding demand for precise immunological research and therapeutic design has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, Recombinant Human LR3 IGF-1 are frequently produced using multiple expression platforms, including bacterial hosts, higher ce